Avalo Therapeutics, Inc.
AVTX
$4.61
-$0.166-3.47%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1,714.51% | 704.11% | 1,381.31% | 560.26% | -43.71% |
Total Receivables | 349.26% | -35.11% | -25.00% | -95.92% | -92.91% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 340.57% | 245.85% | 114.54% | -38.72% | -34.65% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1,800.00% | 4,000.00% | -- | -93.65% | -93.33% |
Total Current Assets | 1,554.44% | 580.53% | 1,175.36% | 477.64% | -48.86% |
|
|||||
Total Current Assets | 1,554.44% | 580.53% | 1,175.36% | 477.64% | -48.86% |
Net Property, Plant & Equipment | -38.47% | -19.17% | -18.20% | -22.93% | -18.50% |
Long-term Investments | 0.00% | -27.11% | -27.11% | -27.11% | -27.11% |
Goodwill | 0.00% | -27.11% | -27.11% | -27.11% | -27.11% |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Assets | 618.01% | 236.37% | 346.90% | 241.46% | -37.08% |
|
|||||
Total Accounts Payable | -36.55% | 129.53% | -12.92% | -83.54% | -84.52% |
Total Accrued Expenses | 195.97% | 42.39% | -28.29% | -49.23% | -83.23% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 5.77% | 2.61% | -96.26% | -94.46% | -91.69% |
Total Finance Division Other Current Liabilities | -52.27% | 2,437.99% | 4,809.98% | 10,947.28% | -17.20% |
Total Other Current Liabilities | -52.27% | 2,437.99% | 4,809.98% | 10,947.28% | -17.20% |
Total Current Liabilities | 50.71% | 910.39% | 329.31% | 827.94% | -79.12% |
|
|||||
Total Current Liabilities | 50.71% | 910.39% | 329.31% | 827.94% | -79.12% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -74.38% | -25.62% | -23.38% | -21.36% | -20.16% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 34.85% | 96.29% | 78.71% | 9.42% | 10.53% |
Total Liabilities | 29.30% | 419.53% | 253.99% | 428.95% | -69.09% |
|
|||||
Common Stock & APIC | 46.97% | 4.20% | 9.40% | 11.83% | 16.91% |
Retained Earnings | -10.48% | -2.43% | -11.26% | -45.46% | -10.31% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 1,721.36% | 43.42% | -95.26% | -1,695.79% | 166.92% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 1,721.36% | 43.42% | -95.26% | -1,695.79% | 166.92% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 1,721.36% | 54.71% | 69.13% | -1,512.97% | 166.92% |
|